PRAXIS PRECISION MEDICINES, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $75.20 million as of 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2021-11-03
- 2021-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $75.20M.
- 2021-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $80.20M.
- 2021-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $81.20M.
- 2020-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $26.70M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2021-09-30 | $75.20M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $80.20M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $81.20M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $26.70M 10-K · filed 2021-03-17 |
| 2020-09-30 | $23.30M 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |